Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Express Scripts Holding Co. (ESRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/29/2019 EFFECT Form EFFECT - Notice of Effectiveness:
07/23/2019 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
06/21/2019 S-4 Form S-4 - Registration of securities, business combinations:
02/13/2019 SC 13G/A Capital World Investors reports a 0% stake in Express Scripts Holding Company
12/31/2018 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
12/27/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/21/2018 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
12/20/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/20/2018 8-K Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-B...
Docs: "Amended and Restated Certificate of Incorporation of Express Scripts Holding Company",
"Amended and Restated Bylaws of Express Scripts Holding Company",
"Second Supplemental Indenture, by and among Express Scripts Holding Company, Cigna Holding Company (formerly known as Cigna Corporation) and U.S. Bank National Association, as Trustee, to that certain base indenture, by and among Halfmoon Parent, Inc. (now known as Cigna Corporation) and U.S. Bank National Association (as supplemented by that certain first supplemental indenture thereto dated as of September 17, 2018)",
"Additional Guarantor Supplement, by Express Scripts Holding Company and Cigna Holding Company (formerly known as Cigna Corporation) to that certain Revolving Credit and Letter of Credit Agreement, by and among Cigna Corporation (now known as Cigna Holding Company), Halfmoon Parent, Inc. (now known as Cigna Corporation), JPMorgan Chase Bank, N.A., as administrative agent, and the other parties thereto",
"Additional Guarantor Supplement, by Express Scripts Holding Company and Cigna Holding Company (formerly known as Cigna Corporation) to that certain Term Loan Credit Agreement, by and among Cigna Corporation (now known as Cigna Holding Company), Halfmoon Parent, Inc. (now known as Cigna Corporation), Morgan Stanley Senior Funding, Inc., as administrative agent, and the other parties thereto",
"Twenty-Fifth Supplemental Indenture, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Express Scripts Holding Company and Wells Fargo Bank, National Association, as Trustee, to that certain base indenture, by and between Express Scripts Holding Company and Wells Fargo Bank, National Association",
"Ninth Supplemental Indenture, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Express Scripts, Inc. and MUFG Union Bank, N.A. (as successor to Union Bank, N.A.), as Trustee, to that certain base indenture, by and among Express Scripts, Inc., certain subsidiaries of Express Scripts, Inc. and MUFG",
"Second Supplemental Indenture, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Medco Health Solutions, Inc. and U.S. Bank Trust National Association, as Trustee, to that certain base indenture, by and between Medco Health Solutions, Inc. and U.S. Bank Trust National Association",
"Cigna Completes Combination with Express Scripts, Establishing a Blueprint to Transform the Health Care System"
12/19/2018 8-K Regulation FD Disclosure
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report : December 19, 2018 EXPRESS SCRIPTS HOLDING COMPANY Delaware 001-35490 45-2884094 File Number) Identification No.) One Express Way, St. Louis, MO 63121 Registrant's telephone number, including area code 314-996-0900 Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act &#974..."
12/13/2018 8-K Regulation FD Disclosure
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report : December 13, 2018 EXPRESS SCRIPTS HOLDING COMPANY Delaware 001-35490 45-2884094 File Number) Identification No.) One Express Way, St. Louis, MO 63121 Registrant's telephone number, including area code 314-996-0900 Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act &#974..."
11/21/2018 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Letter Agreement, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc",
"Letter Agreement, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc"
10/31/2018 10-Q Quarterly Report for the period ended September 30, 2018
10/31/2018 8-K Quarterly results
Docs: "Express Scripts Announces 2018 Third Quarter Results ST. LOUIS, October 31, 2018 — Express Scripts Holding Company announced consolidated 2018 third quarter net income of $1,071.6 million or $1.89 per diluted share. Consolidated 2018 third quarter adjusted earnings per diluted share were $2.43, which represents growth of 28% over consolidated 2017 third quarter adjusted earnings per diluted share. /1 “Our momentum is strong: we achieve industry-leading drug trend, specialized care for patients and breakthrough pharmacy and healthcare solutions, which have helped us achieve strong client retention and increased interest from prospects. Across the board we are driving strong results, as we did in the third quarter,” said Tim Wentworth, President and CEO. “As we look ahead to our planned comb..."
09/18/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "FORM 8-K",
"U.S. DEPARTMENT OF JUSTICE GRANTS CLEARANCE TO CIGNA'S ACQUISITION OF EXPRESS SCRIPTS"
08/29/2018 8-K Regulation FD Disclosure
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : August 29, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report"
08/24/2018 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "FORM 8-K",
"Express Scripts Stockholders Approve Acquisition by Cigna ST. LOUIS, Aug. 24, 2018 /PRNewswire/ - Stockholders of Express Scripts Holding Company today approved the proposed acquisition of Express Scripts by Cigna. Based on a preliminary tabulation, approximately 78 percent of the shares of Express Scripts common stock outstanding and entitled to vote adopted the Agreement and Plan of Merger with Cigna and certain of its subsidiaries. These shares represent more than 99 percent of the shares voted at a special meeting of shareholders held earlier today. Earlier today, Cigna announced that its stockholders also adopted the merger agreement. The transaction remains subject to the satisfaction of customary closing conditions, including applicable regulatory approvals. Express Scripts expects ..."
08/16/2018 425 Form 425 - Prospectuses and communications, business combinations:
08/15/2018 425 Form 425 - Prospectuses and communications, business combinations:
08/13/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "FORM 8-K",
"Express Scripts Reminds Stockholders to Vote “FOR” the Merger"
08/13/2018 425 Form 425 - Prospectuses and communications, business combinations:
08/10/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : August 10, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report",
"Leading Proxy Advisory Firm ISS Recommends Express Scripts Stockholders Vote “FOR” Merger with Cigna"
08/10/2018 425 Form 425 - Prospectuses and communications, business combinations:
08/09/2018 425 Form 425 - Prospectuses and communications, business combinations:
08/09/2018 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/01/2018 425 Form 425 - Prospectuses and communications, business combinations:
08/01/2018 10-Q Quarterly Report for the period ended June 30, 2018
08/01/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : August 1, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report",
"Express Scripts Announces 2018 Second Quarter Results - Reports 13% Consolidated GAAP Earnings Per Diluted Share Growth - Raises Core Adjusted EBITDA Guidance Range - Increases Client Retention Level - Projects 2% to 3% Core Adjusted Claims Growth for 2019 ST. LOUIS, August 1, 2018 — Express Scripts Holding Company announced consolidated 2018 second quarter net income of $877.3 million or $1.55 per diluted share. Consolidated 2018 second quarter adjusted earnings per diluted share were $2.22, which represents growth of 28% over consolidated 2017 second quarter adjusted earnings per diluted share.* The Company increased its 2018 core business¹ adjusted EBITDA* guidance from a range of $5,250 million to $5,400 million to a range of $5,275 million to $5,425 million, which represents growth of..."
07/27/2018 425 Form 425 - Prospectuses and communications, business combinations:
07/20/2018 425 Form 425 - Prospectuses and communications, business combinations:
07/16/2018 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
07/02/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment No. 1 to the Agreement and Plan of Merger, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc",
"Amendment No. 1 to the Agreement and Plan of Merger, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy